SPECIAL COMMUNICATION: Rethinking Screening for Breast Cancer and Prostate Cancer (Journal of the American Medical Association)
After 20 years of screening for breast and prostate cancer, several observations can be made. First, the incidence of these cancers increased after the introduction of screening but has never returned to prescreening levels. Second, the increase in the relative fraction of early stage cancers has increased
Although PSA screening eradicated advanced prostate cancer from the population, there was a downside.
According to Welch’s report in August JNCI, one million men were overdiagnosed and overtreated for prostate cancer over the last twenty years.
Why was PSA Screening for Prostate Cancer, a 20 year failed Medical Experiment ? Get the whole story here…
http://jeffreydach.com/2009/10/01/psa-testing-the-failed-medical-experiment-by-jeffrey-dach-md.aspx